EPO and diabetes mellitus: For both diabetic groups blood glucose remained significantly higher compared to controls at the end of the study (unpaired t-tests: control versus diabetes: t (12) = −30.24, p = 1.07 × 10−12; control versus EPO-treated diabetics: t (12) = −17.23, p = 7.875 × 10−10) (see Table 1).